PARACETAMOL & SEDATIVE
     OVERDOSAGE
OVERVIEW
• Considered to be a safe and cheap
  analgesic/anti-pyretic
• OTC
• One of the most common overdosed drugs
  worldwide
• Most common cause of acute hepatic failure
  in the UK & US
OVERVIEW
• Leading indication for hepatic transplantation
  in patients with drug induced liver disease
• Single dose of 10- 15 G can produce clinical
  evidence of liver injury
• Fatal fulminant liver failure is usually
  associated with a dosage of > 25 G
OVERVIEW
• Blood levels of > 30 micg/ml 4 hours after
  ingestion are predictive of severe hepatic
  disease
• Levels < 15 micg/ ml are predictive of low risk
• More risk of damage if liver is already
  damaged by infection (virus), alcohol or other
  illness
OVERVIEW
• Available as suppositories- 120,125,325 & 650
  mg
• Chewtabs- 8 mg
• Pedtabs - 16 mg
• Regular tabs- 325 mg
• Extra strong tabs- 500, 650, 1000 mg
• Drops, suspension
OVERVIEW
• Maximum permissible daily dose : 4 g
• Now has been reduced to 3 g
CLINICAL FEATURES
• Nausea, vomiting, diarrhoea, abdo minal pain,
  shock- first 24 to 48 hours
• Once these symptoms abate, features of
  hepatic injury appears.
• Maximum derangement & hepatic failure
  occurs around day 6
• SGOT/PT maybe raised around 10000
CLINICAL FEATURES
• Coma, convulsions, irritability, seizures
• Renal failure
• myocarditis
PROGNOSIS
• Depends on

• Quantity ingested
• Timing of initiation of treatment
• Pre-morbid health
TREATMENT
• Supportive measures
• Airway
• Breathing circulation
• Gastric lavage- oral administration of activated
  charcoal/ cholestyramine to prevent the
  absorbtion of the residual drug
• Not useful if given > 3 min after ingestion
TREATMENT
• Levels> 200 micg/ml after 4h
• Or 100 micg/ml after 8 hours are indications
• Administration of sulfhydril compounds(
  cystamine, cysteine or NAC) reduces the
  severity of hepatic necrosis.
• They work by acting as a reservoir of – SH
  groups that bind to the toxic metabolytes or
  stimulate the synthesis/ repletion of hepatic
  glutathione
TREATMENT
• Must be given within 8 hours and maybe
  effective upto as late as 24 to 36 hours
• Dose of NAC- 140 mg/kg stat followed by 70
  mg/kg Q4h for 15 to 20 doses
• If evidence of hepatic failure occurs while on
  treatment with NAC, consider LT
• Lactate levels > 3.5 mmol/L is a fair indicator
  of the need for LT
PREVENTION
• Keep all medications out of reach of children
• Know the correct dosage
• Never mix medicines containing
  acetaminophen with other drugs
• Remove all medications out of reach of adults
  if there is a past/ family history of
  suicide/attempt
• Avoid PCM in those who consume > 3 units of
  alcohol/day
BARBITURATE OVERDOSAGE
• Earliest class of hypnotic-sedatives to be
  developed
• Marilyn Monroe & Judy Garland famous victims
• Lethal dose varies according to individual
  tolerance (2-10 G is potentially fatal)
• With other CNS depressants like alcohol,opiates
  or BZD, the severity of barbiturate overdosage is
  amplified.
• Depresses CNS & respiration
BARBITURATE OVERDOSAGE
•   SIGNS & SYMPTOMS
•   Sluggishness, incoordination
•   Difficulty in thinking, slow speech
•   Faulty judgement, drowsiness
•   Shallow breathing, staggering
•   Apnea, hypoxia
BARBITURATE OVERDOSAGE
•   ARDS
•   Paranoia
•   Combativeness
•   Tachycardia, bradycardia, hypotension, Shock
•   Coma, death
BARBITURATE OVERDOSAGE
•   SIGNS
•   Hypothermia
•   Depressed pupillary reflex
•   Nystagmus
•   Squint
•   Supressed DTR
BARBITURATE OVERDOSAGE
TREATMENT
Supportive care/ decontamination/Accelerate
  elimination
Secure airway
Endotracheal intubation- if depressed sensorium,
  respiratory failure, hypoxia, raised ICT
  O2
  Venous access
BARBITURATE OVERDOSAGE
• Naloxone 2 mg. IV to all with depressed
  sensorium
• Measure rectal temperature- rewarming
  measures
• Pressors- noradrenaline, dopamine, fluids
• Decontamination- activated charcoal 1G/kg
  Q6H
• Cathartics, gastric lavage
BARBITURATE OVERDOSAGE
Alkalinise urine
Sodabicarb 1 meq/kg folowed by continuous
  infuson
Add 100- 150 meq of NaHco3 to 850 ml of D5 %
Dialysis- hemofiltration preferred over HD
Intravenous lipid emulsion (ILE) is emerging as
  an antidote
TRICYCLIC ANTIDEPRESSANTS
• One of the most dangerous drugs
• Anti-cholinergic and cardiac depressant
  properties(Quinidine like NA+ channel
  blockade)
• Newer anti-depressants like sertraline,
  fluoxetine, fluvoxamine, citalopram,
  bupropion, trazodone, venlaflaxine etc. are
  structurally unrelated to TCAD and produce
  less cardiotoxicity
TRICYCLIC ANTIDEPRESSANTS
• They can produce seizures & serotonin
  syndrome
• S & S may occur abruptly in around 30-60
  minutes
• Anti-cholinergic effects- dilated pupils,
  tachycardia, dry mouth, flushed skin,
  fasciculations & reduced peristalsis
TRICYCLIC ANTIDEPRESSANTS
• Cardiotoxicity- widens QRSc leading to
  ventricular arrhythmias, AV block, and
  hypotension
• Prolonged QT – Venlaflaxine, Citalopram
• Severe intoxication- coma, seizures especially
  Venlaflaxine & Bupropion
• Hyperthermia- due to anticholinergic induced
  reduced sweating
TRICYCLIC ANTIDEPRESSANTS
• Diagnosed by the combination of
  anticholinergic side effects & prolonged QRSc
  with seizures
• Degree of widening of the QRSc corelates
  directly with the severity of intoxication rather
  than the drug levels
• Serotonin syndrome- agitation, delirium,
  muscular hyperactivity, fever
TRICYCLIC ANTIDEPRESSANTS
• TREATMENT
• Observe all cases for atleast 6 hours
• Admit all patients with anti-cholinergic effects
  or cardiotoxicity
• Activated charcoal, gastric lavage
• Cannot be removed by dialysis as they are
  highly tissue bound
TRICYCLIC ANTIDEPRESSANTS
• SPECIFIC TREATMENT
• NAHCO3 50 to 10 meq IV- alleviates the NA –
  channel depressing effect
• Maintain pH between 7.45- 7.50
• IV MG or overdrive pacing for long QT sy
  ndrome/Torsades de pointes
• Serotonin syndrome- Benzodiazepines,
  cyproheptadine 4 mg P/O 3 to 4 doses
TRICYCLIC ANTIDEPRESSANTS
• Severe hyperthermia

• neuromuscular paralysis
• External cooling
• intubation

Paracetamol and sedative overdosage

  • 1.
  • 2.
    OVERVIEW • Considered tobe a safe and cheap analgesic/anti-pyretic • OTC • One of the most common overdosed drugs worldwide • Most common cause of acute hepatic failure in the UK & US
  • 3.
    OVERVIEW • Leading indicationfor hepatic transplantation in patients with drug induced liver disease • Single dose of 10- 15 G can produce clinical evidence of liver injury • Fatal fulminant liver failure is usually associated with a dosage of > 25 G
  • 4.
    OVERVIEW • Blood levelsof > 30 micg/ml 4 hours after ingestion are predictive of severe hepatic disease • Levels < 15 micg/ ml are predictive of low risk • More risk of damage if liver is already damaged by infection (virus), alcohol or other illness
  • 5.
    OVERVIEW • Available assuppositories- 120,125,325 & 650 mg • Chewtabs- 8 mg • Pedtabs - 16 mg • Regular tabs- 325 mg • Extra strong tabs- 500, 650, 1000 mg • Drops, suspension
  • 6.
    OVERVIEW • Maximum permissibledaily dose : 4 g • Now has been reduced to 3 g
  • 7.
    CLINICAL FEATURES • Nausea,vomiting, diarrhoea, abdo minal pain, shock- first 24 to 48 hours • Once these symptoms abate, features of hepatic injury appears. • Maximum derangement & hepatic failure occurs around day 6 • SGOT/PT maybe raised around 10000
  • 8.
    CLINICAL FEATURES • Coma,convulsions, irritability, seizures • Renal failure • myocarditis
  • 9.
    PROGNOSIS • Depends on •Quantity ingested • Timing of initiation of treatment • Pre-morbid health
  • 10.
    TREATMENT • Supportive measures •Airway • Breathing circulation • Gastric lavage- oral administration of activated charcoal/ cholestyramine to prevent the absorbtion of the residual drug • Not useful if given > 3 min after ingestion
  • 11.
    TREATMENT • Levels> 200micg/ml after 4h • Or 100 micg/ml after 8 hours are indications • Administration of sulfhydril compounds( cystamine, cysteine or NAC) reduces the severity of hepatic necrosis. • They work by acting as a reservoir of – SH groups that bind to the toxic metabolytes or stimulate the synthesis/ repletion of hepatic glutathione
  • 12.
    TREATMENT • Must begiven within 8 hours and maybe effective upto as late as 24 to 36 hours • Dose of NAC- 140 mg/kg stat followed by 70 mg/kg Q4h for 15 to 20 doses • If evidence of hepatic failure occurs while on treatment with NAC, consider LT • Lactate levels > 3.5 mmol/L is a fair indicator of the need for LT
  • 13.
    PREVENTION • Keep allmedications out of reach of children • Know the correct dosage • Never mix medicines containing acetaminophen with other drugs • Remove all medications out of reach of adults if there is a past/ family history of suicide/attempt • Avoid PCM in those who consume > 3 units of alcohol/day
  • 14.
    BARBITURATE OVERDOSAGE • Earliestclass of hypnotic-sedatives to be developed • Marilyn Monroe & Judy Garland famous victims • Lethal dose varies according to individual tolerance (2-10 G is potentially fatal) • With other CNS depressants like alcohol,opiates or BZD, the severity of barbiturate overdosage is amplified. • Depresses CNS & respiration
  • 15.
    BARBITURATE OVERDOSAGE • SIGNS & SYMPTOMS • Sluggishness, incoordination • Difficulty in thinking, slow speech • Faulty judgement, drowsiness • Shallow breathing, staggering • Apnea, hypoxia
  • 16.
    BARBITURATE OVERDOSAGE • ARDS • Paranoia • Combativeness • Tachycardia, bradycardia, hypotension, Shock • Coma, death
  • 17.
    BARBITURATE OVERDOSAGE • SIGNS • Hypothermia • Depressed pupillary reflex • Nystagmus • Squint • Supressed DTR
  • 18.
    BARBITURATE OVERDOSAGE TREATMENT Supportive care/decontamination/Accelerate elimination Secure airway Endotracheal intubation- if depressed sensorium, respiratory failure, hypoxia, raised ICT O2 Venous access
  • 19.
    BARBITURATE OVERDOSAGE • Naloxone2 mg. IV to all with depressed sensorium • Measure rectal temperature- rewarming measures • Pressors- noradrenaline, dopamine, fluids • Decontamination- activated charcoal 1G/kg Q6H • Cathartics, gastric lavage
  • 20.
    BARBITURATE OVERDOSAGE Alkalinise urine Sodabicarb1 meq/kg folowed by continuous infuson Add 100- 150 meq of NaHco3 to 850 ml of D5 % Dialysis- hemofiltration preferred over HD Intravenous lipid emulsion (ILE) is emerging as an antidote
  • 21.
    TRICYCLIC ANTIDEPRESSANTS • Oneof the most dangerous drugs • Anti-cholinergic and cardiac depressant properties(Quinidine like NA+ channel blockade) • Newer anti-depressants like sertraline, fluoxetine, fluvoxamine, citalopram, bupropion, trazodone, venlaflaxine etc. are structurally unrelated to TCAD and produce less cardiotoxicity
  • 22.
    TRICYCLIC ANTIDEPRESSANTS • Theycan produce seizures & serotonin syndrome • S & S may occur abruptly in around 30-60 minutes • Anti-cholinergic effects- dilated pupils, tachycardia, dry mouth, flushed skin, fasciculations & reduced peristalsis
  • 23.
    TRICYCLIC ANTIDEPRESSANTS • Cardiotoxicity-widens QRSc leading to ventricular arrhythmias, AV block, and hypotension • Prolonged QT – Venlaflaxine, Citalopram • Severe intoxication- coma, seizures especially Venlaflaxine & Bupropion • Hyperthermia- due to anticholinergic induced reduced sweating
  • 24.
    TRICYCLIC ANTIDEPRESSANTS • Diagnosedby the combination of anticholinergic side effects & prolonged QRSc with seizures • Degree of widening of the QRSc corelates directly with the severity of intoxication rather than the drug levels • Serotonin syndrome- agitation, delirium, muscular hyperactivity, fever
  • 25.
    TRICYCLIC ANTIDEPRESSANTS • TREATMENT •Observe all cases for atleast 6 hours • Admit all patients with anti-cholinergic effects or cardiotoxicity • Activated charcoal, gastric lavage • Cannot be removed by dialysis as they are highly tissue bound
  • 26.
    TRICYCLIC ANTIDEPRESSANTS • SPECIFICTREATMENT • NAHCO3 50 to 10 meq IV- alleviates the NA – channel depressing effect • Maintain pH between 7.45- 7.50 • IV MG or overdrive pacing for long QT sy ndrome/Torsades de pointes • Serotonin syndrome- Benzodiazepines, cyproheptadine 4 mg P/O 3 to 4 doses
  • 27.
    TRICYCLIC ANTIDEPRESSANTS • Severehyperthermia • neuromuscular paralysis • External cooling • intubation